Keywords: salmedix, completes, trial, oral, cancer, drug, development

Salmedix completes trial of oral cancer drug

Article | 06 December 2001

Print This

US cancer drug development specialist Salmedix has completed a Phase Iclinical trial of SDX-101, a new agent being developed for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in